Histogenics sets the per-share price range for its upcoming initial public offering, setting the midpoint at $60 million.
Histogenics set the per-share price range on its forthcoming initial public offering at $13 to $15 per share.
That puts the mid-point for the nearly 4.3 million-share offering at just under $60 million.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1uFp9A9
Cap comentari:
Publica un comentari a l'entrada